Shoshana Grossman, MD
Dermatology · Philadelphia, PANPI 1720511074
Payments from drug & device makers
Across 204 payments — averaging $18.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$886
- Johnson & Johnson$640
- Sanofi$309
- Sun Pharmaceutical Industries Inc.$308
- Kerecis Limited$227
- Arcutis Biotherapeutics, Inc.$195
- plus $1K from 15 others
What the payments were for
- Food & beverage$3,46193%
- Education$2427%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 68 | $886 |
| Johnson & Johnson | 26 | $640 |
| Sanofi | 12 | $309 |
| Sun Pharmaceutical Industries Inc. | 23 | $308 |
| Kerecis Limited | 7 | $227 |
| Arcutis Biotherapeutics, Inc. | 15 | $195 |
| Organon | 13 | $148 |
| E.r. Squibb & Sons, L.L.C. | 7 | $141 |
| Regeneron Healthcare Solutions, Inc. | 4 | $140 |
| Incyte Corporation | 5 | $136 |
| Mayne Pharma Commercial LLC | 6 | $135 |
| Galderma Laboratories, L.p. | 5 | $99 |
| Sanofi-aventis U.S. LLC | 1 | $80 |
| Amgen | 2 | $63 |
| Helsinn Therapeutics (U.S.), Inc. | 3 | $58 |
| Pfizer | 2 | $38 |
| Lilly USA, LLC | 1 | $30 |
| Novartis | 1 | $22 |
| Verrica Pharmaceuticals Inc. | 1 | $18 |
| Journey Medical Corporation | 1 | $15 |
| Dermavant Sciences, Inc. | 1 | $14 |
How this compares
$3,703 in reported general payments places this provider in the 60th percentile of 626 dermatology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 21 | $79,083 |
| Clobetasol Propionate | 62 | $2,169 |
| Tretinoin | 26 | $1,187 |
| Tacrolimus | 12 | $1,061 |
| Halobetasol Propionate | 13 | $881 |
| Ketoconazole | 39 | $458 |
| Metronidazole | 11 | $452 |
| Clindamycin Phosphate | 17 | $310 |
| Ammonium Lactate | 18 | $272 |
| Triamcinolone Acetonide | 23 | $266 |
| Doxycycline Hyclate | 15 | $193 |
| Mupirocin | 27 | $167 |
| Minoxidil | 15 | $152 |
| Hydrocortisone | 25 | $111 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Philadelphia
- Victoria WerthPhiladelphia$7.2M
- Joel GelfandPhiladelphia$3.6M
- Lawrence ParishPhiladelphia$2.9M
- Stephen HessPhiladelphia$1.7M
- Susan TaylorPhiladelphia$939K
- Jennifer ParishPhiladelphia$926K
- Nicholas MollanazarPhiladelphia$509K
- Zelma Chiesa FuxenchPhiladelphia$396K
- Katrina AbuabaraPhiladelphia$359K
- Joy WanPhiladelphia$358K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.